Quarterly Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7246013

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,832,363,000 JPY
-1,277,127,000 JPY
Net cash provided by (used in) operating activities
-1,834,577,000 JPY
-1,279,615,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-116,000 JPY
-1,132,000 JPY
Net cash provided by (used in) investing activities
-206,000 JPY
207,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
756,696,000 JPY
1,853,195,000 JPY
Effect of exchange rate change on cash and cash equivalents
-145,000 JPY
-1,065,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,078,232,000 JPY
572,721,000 JPY
Cash and cash equivalents
338,829,000 JPY
1,417,062,000 JPY
844,341,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.